ACE2 and breast cancer: suggested that breast tumor tissues can be further reduced at ACE2 expression level (angiotensin-converting enzyme 2) after SARS-CoV-2 infection, which further deteriorates immune infiltration and worsens the prognosis of luminal B breast cancer after SARS-CoV-2 infection (45).